TICKERNERD
Menu
NTHINTHIHealthcare · Biotechnology

NTHI Stock Forecast: NeOnc Technologies Holdings, Inc. Price Predictions for 2026-2027

Last close, 3 Aug 2026
$3.46
−0.86% on the day

The 3 Wall Street analysts covering NeOnc Technologies Holdings, Inc. hold a median 12-month price target of $15 — +333.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 17 of 100 as at 1 Aug 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$90.5M
Ticker Nerd rank
17 / 100
Median analyst target
$15
Analysts covering
3
Total return, dividends reinvested
1W
+0.6%
1M
−21.7%
YTD
−58.2%
1Y
−27.2%
From 52W high
−71.4%
From 52W low
+6.5%
$3
$12
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

NTHI stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores NeOnc Technologies Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026
17 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
76
Accruals
64
Value
61
Revisions
41
Momentum
26
Volatility
13
Quality
11
Growth
8
Issuance
7

Size (76): Smaller than most of the companies we track.

Issuance (7): The company has been issuing shares or taking on financing, diluting existing holders.

The rank is the raw material. Whether the rules would actually own NeOnc Technologies Holdings, Inc. — and when they’d sell — is the membership.

Wall Street

NTHI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on NTHI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$5$10$15$20Oct 25Jan 26Apr 26Jul 26NTHIHigh $20Median $15Low $13

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says3 analysts
3 Buy0 Hold0 Sell
Low $13Median $15High $20

The green dot is the last close — the median target sits +333.5% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
26 May 2026BTIGReiteratesBuy$15
19 May 2026Alliance Global PartnersInitiatesBuy$13
18 May 2026Maxim GroupInitiatesBuy—
24 Apr 2026BTIGInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

NTHI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
1
Fundamentals

NeOnc Technologies Holdings, Inc. (NTHI) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−1.1×

Cheaper than 82% of US stocks

Price / sales
2263.1×

Cheaper than 1% of US stocks

Price / book
−6.0×

Cheaper than 97% of US stocks

EV / EBITDA
−1.5×

Cheaper than 70% of US stocks

Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
−100.0%

Higher than 1% of US stocks

Gross margin
—
Operating margin
−149141.4%

Higher than 1% of US stocks

Net margin
0.0%

Higher than 30% of US stocks

Returns & dividend
Return on equity
355.0%

Higher than 99% of US stocks

Return on assets
−354.6%

Higher than 1% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

NTHI vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelBiotechnology
CompanyMarket capTKN rank
NTHINeOnc Technologies Holdings, Inc.$90.5M
17
ACETAdicet Bio, Inc.$87.3M
43
VRCAVerrica Pharmaceuticals, Inc.$89.7M
85
RLYBRallybio Corp.$84.1M
58
TELOTelomir Pharmaceuticals, Inc.$83.2M
17
HRTXHeron Therapeutics, Inc.$91.0M
42
GOSSGossamer Bio, Inc.$82.9M
32
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NTHI appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

News

Latest NTHI news & analysis

NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors

GlobeNewsWire · 27 July 2026positive

NeOnc Technologies announced the appointment of Nasim Shomali, a strategy and finance executive, to its Board of Directors, effective July 1, 2026.

Why it matters — Adding an executive with strategy and finance expertise to the board could strengthen the company's corporate governance and financial oversight as it advances its CNS cancer therapies through Phase 2 clinical trials.

FAQ

Frequently asked questions about NTHI stock

What is the NTHI stock price forecast for 2026-2027?

The 3 Wall Street analysts covering NeOnc Technologies Holdings, Inc. have a median 12-month price target of $15, with estimates ranging from $13 to $20. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is NTHI stock a buy right now?

Of the 3 analysts covering NeOnc Technologies Holdings, Inc., 3 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks NeOnc Technologies Holdings, Inc. 17 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank NTHI?

As at 1 Aug 2026, NeOnc Technologies Holdings, Inc. ranks 17 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (76 of 100).

Will NTHI stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +333.5% from the last close, and Ticker Nerd's factor model ranks NeOnc Technologies Holdings, Inc. 17 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the NTHI stock forecast for 2030?

No analyst covering NeOnc Technologies Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NTHI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $13 to $20 over the next 12 months.

How has NTHI stock performed over the past year?

NeOnc Technologies Holdings, Inc. returned -27.2% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does NeOnc Technologies Holdings, Inc. do?

NeonC Technologies Holdings is a versatile entity operating in the technology sector. Primarily focused on driving innovation, the company develops cutting-edge software solutions designed to enhance operational efficiencies across various industries.

What is the latest news on NTHI?

The most recent item we track (GlobeNewsWire, 27 July 2026): "NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors". NeOnc Technologies announced the appointment of Nasim Shomali, a strategy and finance executive, to its Board of Directors, effective July 1, 2026.

Company

About NeOnc Technologies Holdings, Inc.

NeonC Technologies Holdings is a versatile entity operating in the technology sector. Primarily focused on driving innovation, the company develops cutting-edge software solutions designed to enhance operational efficiencies across various industries. Leveraging advanced technologies such as artificial intelligence and machine learning, NeonC Technologies targets sectors including healthcare, finance, and logistics, providing tailor-made solutions that streamline complex processes. The company's commitment to research and development positions it as a significant player in the digital transformation landscape, fostering technological advancements and enabling organizations to adapt to rapidly changing market demands. This dedication not only underscores its role in pushing technological boundaries but also in bolstering the overall growth of the tech industry.

CEO Mr. Amir Farrokh Heshmatpour · 5 employees · United States · https://www.neonc.com